3-nitropropionic acid has been researched along with Mental Disorders in 3 studies
3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE
3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group.
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakraborty, J | 1 |
| Nthenge-Ngumbau, DN | 1 |
| Rajamma, U | 1 |
| Mohanakumar, KP | 1 |
| Sheline, CT | 1 |
| Zhu, J | 1 |
| Zhang, W | 1 |
| Shi, C | 1 |
| Cai, AL | 1 |
| Picconi, B | 1 |
| Passino, E | 1 |
| Sgobio, C | 1 |
| Bonsi, P | 1 |
| Barone, I | 1 |
| Ghiglieri, V | 1 |
| Pisani, A | 1 |
| Bernardi, G | 1 |
| Ammassari-Teule, M | 1 |
| Calabresi, P | 1 |
3 other studies available for 3-nitropropionic acid and Mental Disorders
| Article | Year |
|---|---|
Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease.
Topics: Animals; Convulsants; Dendritic Spines; Disease Models, Animal; Dose-Response Relationship, Drug; Dr | 2014 |
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; | 2013 |
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.
Topics: Acetylcholine; Animals; Behavior, Animal; Cholinergic Fibers; Convulsants; Disease Models, Animal; E | 2006 |